Introduction
Nicardipine is a calcium channel blocker similar to nifedipine in structure and actions. It has been reported to have no effects on the sino-atrial and atrio-ventricular nodes and no direct effects on the myocardium. Nicardipine has a serum half-life of 7-8 h after multiple-dosing in man. In this study we assessed the efficacy of nicardipine as a hypotensive agent during ambulatory intraarterial blood pressure monitoring and cardiovascular reflex testing. The assessment of baroreflex sensitivity after nicardipine has been described in detail by us (Young et al., 1984) .
Methods
We studied eight patients with essential hypertension who had no evidence of target organ damage. Essential hypertension was defined as three separate outpatient cuff pressures of 140/90 mm Hg or more after 5 min supine rest (Phase V diastolic). Five patients were male, three were female, and their average age was 49 years (range 36-64 years). The average outpatient clinic cuff pressure for the group was 180/100 + 27/12 mm Hg (+s.d.).
Intra-arterial pressure was measured from the brachial artery in the patient's non-dominant arm, by a 1 mm diameter Teflon cannula which was connected via a transducer and perfusion pump to a miniature analogue tape recorder. Heart rate was recorded onto the same apparatus (Littler et al., 1972) .
Following beat-to-beat computer analysis of the tapes, the intra-arterial blood pressure profile was divided into waking and sleeping periods, the latter being taken from the time of retirement to 115S the time of arousal, as indicated on diary cards. Blood pressure variability was measured as the standard deviation of a normally distributed frequency histogram (Watson et al., 1979 (Smyth et al., 1969) . A linear relationship is observed when pulse interval is plotted against systolic blood pressure and analysed beat by beat after exclusion of inspiratory beats. The slope of the regression line of pulse interval on systolic blood pressure is a measure of the sensitivity of the sino-aortic baroreflex. The set point of this reflex is determined from resting values of blood pressure and the corresponding pulse interval before injection of phenylephrine.
Protocol
Patients were admitted to an open ward and allowed to acclimatise. Arterial cannulation was performed early the next morning, and the line was connected to the Grass recorder. After an hour's acclimatisation, the reflex tests were performed. Following these, the arterial line was connected to the ambulatory blood pressure equipment. A diary card was then provided, and the subject was told to be active within the confines of the hospital grounds.
Patients received 30 mg of nicardipine orally at 08.00 h the following morning. At 09.00 h the arterial cannula was reconnected to the Grass recorder, and the protocol was repeated as above. Patients were allowed home at 18.00 h after the single dose and then were treated for 2 months with oral nicardipine 20, 30, or 40 mg at 08.00, 14.00 and 20.00 h. The dose was titrated in the Hypertension Clinic, and a fall in mean cuff pressure of 10% was regarded as a satisfactory response. After 2 months of outpatient treatment the patients were readmitted, and the measurements were repeated following the same protocol described above. Figure 1 Blood pressure and heart rate observations before and after single-dose and multiple-dose nicardipine therapy. The resting (El) maximum levels of blood pressure were lower after nicardipine therapy, but there was no significant alteration in the change in pressure and heart rate with respect to tilt for 15 min at 600 (e).
Intra-arterial blood pressure After treatment for 2 months the 24 h mean intra-arterial blood pressure fell from 161/ 102+9/13 to 147/93+70/12 mm Hg(P < 0.05); during the waking period mean intra-arterial blood pressure fell from 165/105+6/12 to 150/96+14/12mm Hg (P < 0.05). Mean systolic variability did not change during the waking period (17 + 2 control vs. 17 + 4 mm Hg) and diastolic variability similarly remained unaltered (12 + 2 control vs 13 + 2 mm Hg).
Heart rate There was no significant difference in heart rate after chronic nicardipine therapy (84 + 12 control vs 80 + 9 beats min-').
Cardiovascular reflexes (i) Tilt Compared with pretreatment control, systolic and diastolic blood pressure were lower in the supine position and at 600 tilt after both the single and multiple doses of nicardipine ( Figure  1 ). There was no evidence ofpostural hypotension. Heart rate (HR) was increased in the supine and tilt position after the single dose of nicardipine, but after chronic therapy the mean supine heart rate had returned to the control value.
(ii) Valsalva manoeuvre After the single and multiple doses the mean arterial pressure was reduced significantly during all phases (Figure 2 ). Heart rate was significantly increased during all phases following the single dose but was slower than control values in all phases after multipledose treatment, though this did not achieve statistical significance. The Valsalva ratio remained unchanged (ratio 1.5 + 0.2 control vs 1.4 + 0.1 single dose vs 1.5 + 0.1 multiple dose).
(iii) Handgrip exercise Resting and maximal systolic blood pressure were reduced significantly in the single-dose study; after multiple doses, maximal systolic blood pressure wa; not significantly. After the single heart rate was increased significantlI to control levels after multiple-do The magnitude of the pressor resp significantly different from conti treatment group (Table 1) .
(iv) Sino-aortic baroreflex sensitivil the mean values ofthe slopes for all r made during the control and treatm shown in Figure 3 . After a single point of the reflex moved to the lefl significant fall in mean systolic I downwards, indicating a significar heart rate (reduction in pulse inter) P < 0.05). This acute response to the drug demonstrates deactivation of the baroreflex mechanism (a tachycardia in response to the acute fall in blood pressure). However, the set point of the baroreflex was quite different after chronic treatment. There was a continuing shift of the set point to the left, i.e. a persisting fall in blood pressure, but the mean HR returned to control values (t = 0.63, P = NS), indicating that resetting of the baroreflex mechanisms occurred in order to buffer pressure at a lower level. These observations are in keeping with the failure ofnicardipine to reduce blood pressure variability over prolonged periods. Our observations on baroreflex activity and reflex cardiac control confirm our previous experience with nifedipine (McLeay et al., 1983) and, furthermore, show that resetting already has occurred by 8 weeks. This study does not explain the precise mechanism responsible for resetting. However, resetting could be caused by changes in the sino-aortic baroreceptors themselves, changes at the sino-atrial node, or centrally. Our observations suggest that in hypertensive man nicardipine and nifedipine have little, if any, direct negative chronotropic effect at the sino-atrial node. Direct recording of carotid sinus discharge frequency in isolated carotid sinuses of experimental animals suggest that over the course of a few days the baroreceptors adapt to acute changes in blood pressure, with discharge frequency rapidly returning towards control levels (Sleight et al., 1977) . We favour baroreceptor adaptation as the mechanism responsible for baroreflex resetting in our hypertensive patients.
Side effects
In contrast to our study using nifedipine, nicardipine did not cause an increase in baroreflex sensitivity, suggesting that facilitation of baroreflex buffering or arterial pressure changes is not essential for the hypotensive effects of calcium channel antagonists.
We conclude that nicardipine is useful as monotherapy in the treatment of mild to moderate hypertension. Simultaneous treatment with beta blockers to reduce heart rate, although often recommended, is not necessary as the baroreflex arc resets during long-term treatment. Furthermore, the absence of fluid retention and weight gain may give this type ofcalcium channel blocker an advantage over other vasodilators in the management of essential hypertension.
